International, Peer Reviewed, Open Access Journal
Annals of Hematology and Oncology Research (ISSN: 2692-7950) is a peer- reviewed, open access, international journal published by Medtext Publications. This journal covers clinical and experimental work which includes Hematology, Oncology, hemostaseology, blood transfusion and other related aspects including molecular biology, blood diseases, Epidemiology, Etiology, Diagnosis, Prognosis, Management and Treatment.
Annals of Hematology and Oncology Research (ISSN: 2692-7950) is a peer- reviewed, open access, international journal published by Medtext Publications. This journal covers clinical and experimental work which includes Hematology, Oncology, hemostaseology, blood transfusion and other related aspects including molecular biology, blood diseases, Epidemiology, Etiology, Diagnosis, Prognosis, Management and Treatment. Medtext Publications is one of the prestigious and leading publishing house and providing an platform for our researchers, scientists, academicians, clinicians and other expertise in the field of science to publish their work and its reaches globally by making the manuscript available on the internet and the people can study it, gain knowledge from it without subscribing and can visit infinite time. Annals of Hematology and Oncology Research accepts Original article, Review article, Case reports, Case series, Editorial, Perspectives, Short Communications, Surgical techniques on all related work of hematology and oncology. To maintain the quality and standard of the journal, we invite expertise to become a part of our journal as an Editorial Member and provide their guidance which aid in the journal growth and also by contributing their work.
Ann Hematol Oncol Res. 2024;2(1):AHOR-1014 | Open Access
Visceral Leishmaniasis Mimicking Myelodysplastic Syndrome
CASE REPORT Updated Aug 20, 2024 PDF
Ann Hematol Oncol Res. 2022;2(1):AHOR-1013 | Open Access
STATs Inhibitors in Cancer Therapy Strategies
REVIEW ARTICLE Updated Aug 24, 2022 PDF
Ann Hematol Oncol Res. 2022;2(1):AHOR-02-1012 | Open Access
Busulfan, Etoposide and Cyclophosphamide versus High-Dose Melphalan as a Conditioning Regimen for Autologous Hematopoietic Stem Cell Transplantation in Patients with Multiple Myeloma
RESEARCH ARTICLE Updated Mar 14, 2022 PDF
Ann Hematol Oncol Res. 2021;2(1):AHOR-1011 | Open Access
Optimal Management of Haemarthrosis in Patients with Haemophilia in Emergency Room
RESEARCH ARTICLE Updated Jul 08, 2021 PDF
Ann Hematol Oncol Res. 2021;2(1):AHOR-1010 | Open Access
Massive Bone Marrow Carcinomatosis Presenting with Leukoerythroblastic Blood Reaction
IMAGE ARTICLE Updated Apr 30, 2021 PDF